Form 4: Arteris Inc. Director Receives Restricted Stock
Statement of Changes in Beneficial Ownership
Arteris, Inc. Director Claudia F. Munce acquired 860 shares of common stock as fully vested restricted stock, representing retainer fees elected in lieu of cash.
Summary
- Claudia F. Munce, a Director at Arteris, Inc., acquired 860 shares of common stock on April 5, 2026.
- These shares were received as fully vested restricted stock, representing retainer fees elected by Ms. Munce in lieu of cash compensation.
- The restricted stock was granted based on the average trading price of Arteris, Inc. common stock from February 20, 2026, to April 2, 2026, which was $15.98 per share.
- Ms. Munce has elected to defer the receipt of these shares.
- Following this transaction, Ms. Munce beneficially owns 101,711 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard director compensation transaction without indicating significant positive or negative operational or financial developments.
Positives
- Director compensation is being structured in a way that aligns with shareholder interests through stock ownership.
- The company is utilizing a mechanism (restricted stock) to compensate directors, potentially conserving cash.
- The transaction indicates continued directorship and engagement by Claudia F. Munce.
Negatives
- No negative financial or operational information is present in this filing.
Risks
- The value of the restricted stock is subject to market fluctuations in Arteris, Inc.'s common stock price.
- Potential for future stock price volatility impacting the value of director compensation.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding future company performance. It solely reports a change in beneficial ownership.
Management Comments
- "The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash."
- "The Reporting Person elected to defer the receipt of shares."
Industry Context
StockSavvy.ai notes that the use of restricted stock for director compensation is a common practice in the technology sector, aiming to align executive interests with long-term shareholder value and attract/retain talent.
Related Party Transactions
- The acquisition of 860 shares of common stock by Director Claudia F. Munce represents a related party transaction, as it is a form of compensation to a company insider.
Stakeholder Impact
- Shareholders: The transaction represents a non-cash compensation for a director, which is a standard practice. Dilution is minimal given the number of shares involved relative to total outstanding shares.
- Employees: No direct impact on employees is indicated by this filing.
- Management: Reinforces the alignment of director compensation with company stock performance.
Next Steps
- Claudia F. Munce will continue to hold her position as Director at Arteris, Inc.
- The deferred receipt of shares will occur at a future date as per Ms. Munce's election.
Key Dates
| Date | Description |
|---|---|
| 02/20/2026 | Start of the period for calculating the average trading price of Arteris, Inc. common stock. |
| 04/02/2026 | End of the period for calculating the average trading price of Arteris, Inc. common stock. |
| 04/05/2026 | Grant date of the restricted stock and transaction date for the acquisition of common stock. |
| 04/07/2026 | Date of signature for the Form 4 filing. |
Keywords
Arteris Inc., Form 4, SEC Filing, Insider Trading, Restricted Stock, Director Compensation, Claudia F. Munce, Common Stock, Securities Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.